Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2444 | 3620 | 32.4 | 62% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
371 | 29923 | HEPATIC ENCEPHALOPATHY//KETOGENIC DIET//CARNITINE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1117 | 2744 | CARNITINE//L CARNITINE//PROPIONYL L CARNITINE |
19634 | 431 | ACETYL L CARNITINE//ALCAR//ACETYL L CARNITINE ALC |
23557 | 287 | L CARNITINE//CROTONOBETAINE//TRIMETHYLAMMONIUM COMPOUND |
29085 | 158 | MILDRONATE//MET 88//GAMMA BUTYROBETAINE HYDROXYLASE INHIBITOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARNITINE | Author keyword | 366 | 49% | 15% | 540 |
2 | L CARNITINE | Author keyword | 346 | 53% | 13% | 462 |
3 | PROPIONYL L CARNITINE | Author keyword | 89 | 78% | 2% | 58 |
4 | ACETYL L CARNITINE | Author keyword | 87 | 49% | 4% | 131 |
5 | MILDRONATE | Author keyword | 73 | 73% | 2% | 55 |
6 | GAMMA BUTYROBETAINE | Author keyword | 69 | 96% | 1% | 22 |
7 | CARNITINE DEFICIENCY | Author keyword | 63 | 62% | 2% | 65 |
8 | OCTN2 | Author keyword | 63 | 71% | 1% | 50 |
9 | L PROPIONYLCARNITINE | Author keyword | 38 | 93% | 0% | 14 |
10 | CROTONOBETAINE | Author keyword | 24 | 91% | 0% | 10 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CARNITINE | 366 | 49% | 15% | 540 | Search CARNITINE | Search CARNITINE |
2 | L CARNITINE | 346 | 53% | 13% | 462 | Search L+CARNITINE | Search L+CARNITINE |
3 | PROPIONYL L CARNITINE | 89 | 78% | 2% | 58 | Search PROPIONYL+L+CARNITINE | Search PROPIONYL+L+CARNITINE |
4 | ACETYL L CARNITINE | 87 | 49% | 4% | 131 | Search ACETYL+L+CARNITINE | Search ACETYL+L+CARNITINE |
5 | MILDRONATE | 73 | 73% | 2% | 55 | Search MILDRONATE | Search MILDRONATE |
6 | GAMMA BUTYROBETAINE | 69 | 96% | 1% | 22 | Search GAMMA+BUTYROBETAINE | Search GAMMA+BUTYROBETAINE |
7 | CARNITINE DEFICIENCY | 63 | 62% | 2% | 65 | Search CARNITINE+DEFICIENCY | Search CARNITINE+DEFICIENCY |
8 | OCTN2 | 63 | 71% | 1% | 50 | Search OCTN2 | Search OCTN2 |
9 | L PROPIONYLCARNITINE | 38 | 93% | 0% | 14 | Search L+PROPIONYLCARNITINE | Search L+PROPIONYLCARNITINE |
10 | CROTONOBETAINE | 24 | 91% | 0% | 10 | Search CROTONOBETAINE | Search CROTONOBETAINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PLASMA CARNITINE | 119 | 87% | 2% | 59 |
2 | ORGANIC CATION CARNITINE TRANSPORTER | 91 | 73% | 2% | 70 |
3 | TRANSPORTER OCTN2 | 77 | 84% | 1% | 42 |
4 | ACETYL L CARNITINE | 67 | 27% | 6% | 217 |
5 | JUVENILE VISCERAL STEATOSIS | 65 | 84% | 1% | 36 |
6 | DIETARY L CARNITINE | 56 | 65% | 1% | 53 |
7 | DIETARY CARNITINE | 55 | 87% | 1% | 27 |
8 | BUTYROBETAINE HYDROXYLASE INHIBITOR | 53 | 89% | 1% | 24 |
9 | GAMMA BUTYROBETAINE | 52 | 82% | 1% | 31 |
10 | ESTERIFIED CARNITINE | 52 | 87% | 1% | 26 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Risks and Benefits of Carnitine Supplementation in Diabetes | 2015 | 1 | 67 | 58% |
L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis | 2014 | 8 | 62 | 73% |
Carnitine biosynthesis in mammals | 2002 | 254 | 122 | 76% |
L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders | 2014 | 14 | 96 | 38% |
Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management | 2012 | 24 | 24 | 96% |
L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis | 2013 | 23 | 22 | 64% |
Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency | 2012 | 26 | 112 | 79% |
Carnitine and Acylcarnitines Pharmacokinetic, Pharmacological and Clinical Aspects | 2012 | 27 | 175 | 72% |
Analytical approaches to determination of carnitine in biological materials, foods and dietary supplements | 2014 | 4 | 57 | 89% |
Acylcarnitines: Role in brain | 2010 | 63 | 167 | 53% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOQUIM BIOL MOL B | 5 | 55% | 0.2% | 6 |
2 | ANIM NUTR NUTR PHYSIOL | 5 | 19% | 0.6% | 22 |
3 | MED ANGIOL SECT | 4 | 75% | 0.1% | 3 |
4 | GABRIEL | 4 | 41% | 0.2% | 7 |
5 | BIOQUIM BIOL MOL B IMMUNOL | 3 | 50% | 0.1% | 5 |
6 | DIPARTIMENTO RIC CHIM | 3 | 60% | 0.1% | 3 |
7 | ANAT DIAGNOST PATHOL LEGAL MED PUBL HLTH | 2 | 67% | 0.1% | 2 |
8 | CARNITINE DEV | 2 | 67% | 0.1% | 2 |
9 | PREVENT TREATMENT OBES | 1 | 38% | 0.1% | 3 |
10 | SEZ FISIOL NUTR UMANA | 1 | 38% | 0.1% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000041389 | MAPLE SYRUP URINE DISEASE//METHYLMALONIC ACIDEMIA//JOURNAL OF INHERITED METABOLIC DISEASE |
2 | 0.0000013059 | ALPHA LIPOIC ACID//LIPOIC ACID//THIOCTIC ACID |
3 | 0.0000010771 | PEPT1//PEPT2//HPEPT1 |
4 | 0.0000009430 | ALMITRINE//PHARMACOL PHARMACOL BIOTECHNOL//PHARMACOL MOL MED CENT NERVOUS SYST |
5 | 0.0000008151 | TRIMETAZIDINE//DIABETIC CARDIOMYOPATHY//PERHEXILINE |
6 | 0.0000006599 | GRAPTOPETALUM PARAGUAYENSE E WALTHER//AGR CHEM CHIKUSA KU//AGR CHEM NUTR BIOCHEM |
7 | 0.0000006341 | ACUTE NECROTIZING ENCEPHALOPATHY//MARCHIAFAVA BIGNAMI DISEASE//ENCEPHALITIS LETHARGICA |
8 | 0.0000006000 | FLAVIN CONTAINING MONOOXYGENASE//FMO3//TRIMETHYLAMINURIA |
9 | 0.0000005791 | CYSTINOSIS//PANTOTHENATE KINASE//PKAN |
10 | 0.0000005656 | CARDIOPLEGIA//JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//CARIPORIDE |